Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: Brad who wrote (626)	3/18/1998 1:59:00 PM
From: DARPA	Read Replies (2) \| Respond to of 4650

So, is that the explanation? Has the company simply created and sold more shares to someone with deep pockets? That would explain the lack of upward price movement. Wouldn't be a bad thing, necessarily. The company would now have more working capital and share price wouldn't need correcting as the CASH asset would have increased proportionately with the selling of these new shares (hypothesizing here). The downside is that share price may continue to be in a holding pattern until genuine revenues start to drive earnings up. Speculation on expectations of earnings by a wonderful new lung cancer diagnostic and treatment company isn't necessarily going to drive the price up in the near term. If that's the case, I'd like to divest, find something with some movement for this year, and then get back into ADOT as the sales start to ramp. Thoughts? Anyone have timelines as to when Biomoda will begin "shipping" their product(s)?